Heron Therapeutics, Inc. (HRTX)
0.7459
-0.04
(-4.82%)
USD |
NASDAQ |
Mar 30, 16:00
0.7599
+0.01
(+1.88%)
After-Hours: 20:00
Heron Therapeutics Profit Margin (Quarterly) : -7.28% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -5.20% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -6.23% |
| Return on Invested Capital | -13.42% |
| Gross Profit Margin (Quarterly) | 72.61% |
| Operating Margin (Quarterly) | 0.09% |
| Return on Net Operating Assets | -12.17% |